Company Overview#
Ratos AB has announced strong financial results for the first quarter of 2026, showcasing a significant 81% increase in adjusted earnings per share (EPS) compared to the same period last year. The company also reported a 3.4% rise in net sales, indicating a positive trend in its financial health.
Key Financial Highlights#
- Adjusted EPS: 67 Öre, up 81% from Q1 2025.
- Net Sales: SEK 4.49 billion, reflecting a 3.4% year-over-year growth.
- Adjusted EBITDA: SEK 460 million, which is a 21% increase year-over-year, with a margin of 9.3%.
- Organic Growth: Positive for the second consecutive quarter at 3.4%.
Performance Insights#
Ratos's performance in Q1 2026 was bolstered by strong demand in its Industrial Products segment, particularly from Diab, which experienced a 16% organic growth driven by increased demand from defense customers. However, challenges in the Industrial Services segment, particularly with Aibel and Knightec, moderated overall growth.
Market Reaction and Outlook#
Following the earnings report, Ratos's stock price rose by 0.95% in pre-market trading, reflecting investor confidence in the company's strong financial results. The stock remains stable within its 52-week range, indicating potential for future growth. Looking ahead, Ratos has provided guidance for continued growth, with EPS forecasts for the upcoming quarters set at 0.19 USD for Q2 and 0.05 USD for Q3 and Q4, alongside anticipated revenue growth.
Executive Commentary#
CEO Jonas Wiström highlighted the effectiveness of Ratos's strategic initiatives and the company's ability to navigate a complex market environment. He emphasized the focus on driving organic growth and enhancing profitability across the portfolio. However, the company faces risks such as currency fluctuations and cautious market conditions in the Industrial Services segment.